Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA018246 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA018246, RRID:AB_1849204
- Product name
- Anti-FXR1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human FXR1, Gene description: fragile X mental retardation, autosomal homolog 1, Validated applications: WB, IHC, ICC, Uniprot ID: P51114, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Plakophilins 1 and 3 Bind to FXR1 and Thereby Influence the mRNA Stability of Desmosomal Proteins
Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture
Skeletal muscle and related protein expression as prognostic factors in thymic squamous cell carcinoma
Fragile X–Related Protein 1 Regulates Nucleoporin Localization in a Cell Cycle–Dependent Manner
Spatial control of nucleoporin condensation by fragile X‐related proteins
FXR1 expression domain in Wilms tumor
FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion
Fischer-Kešo R, Breuninger S, Hofmann S, Henn M, Röhrig T, Ströbel P, Stoecklin G, Hofmann I
Molecular and Cellular Biology 2023;34(23):4244-4256
Molecular and Cellular Biology 2023;34(23):4244-4256
Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture
Wojcik H, Lovvorn H, Hollingshead M, Pierce J, Stotler H, Murphy A, Borgel S, Phelps H, Correa H, Perantoni A
Frontiers in Oncology 2023;13
Frontiers in Oncology 2023;13
Skeletal muscle and related protein expression as prognostic factors in thymic squamous cell carcinoma
Nakanishi K, Ozeki N, Tateyama H, Kadomatsu Y, Ueno H, Goto M, Nakamura S, Fukumoto K, Chen-Yoshikawa T
Journal of Thoracic Disease 2022;14(9):3245-3254
Journal of Thoracic Disease 2022;14(9):3245-3254
Fragile X–Related Protein 1 Regulates Nucleoporin Localization in a Cell Cycle–Dependent Manner
Agote-Arán A, Lin J, Sumara I
Frontiers in Cell and Developmental Biology 2021;9
Frontiers in Cell and Developmental Biology 2021;9
Spatial control of nucleoporin condensation by fragile X‐related proteins
Agote‐Aran A, Schmucker S, Jerabkova K, Jmel Boyer I, Berto A, Pacini L, Ronchi P, Kleiss C, Guerard L, Schwab Y, Moine H, Mandel J, Jacquemont S, Bagni C, Sumara I
The EMBO Journal 2020;39(20)
The EMBO Journal 2020;39(20)
FXR1 expression domain in Wilms tumor
Phelps H, Pierce J, Murphy A, Correa H, Qian J, Massion P, Lovvorn H
Journal of Pediatric Surgery 2019;54(6):1198-1205
Journal of Pediatric Surgery 2019;54(6):1198-1205
FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion
Fan Y, Yue J, Xiao M, Han-Zhang H, Wang Y, Ma C, Deng Z, Li Y, Yu Y, Wang X, Niu S, Hua Y, Weng Z, Atadja P, Li E, Xiang B
eLife 2017;6
eLife 2017;6
No comments: Submit comment
No validations: Submit validation data